DOI:
10.1055/s-00034915
Onkologische Welt
LinksClose Window
References
Masini C. et al
Nivolumab (NIVO) in combination with stereotactic body radiotherapy (SBRT) in pretreated patients (pts) with metastatic renal cell carcinoma (mRCC): First results of phase II NIVES study ASCO-GU.
2020 Abstract 613
Access:
We do not assume any responsibility for the contents of the web pages of other providers.